Marc H. Smith is a prominent researcher in the field of neurodegenerative diseases, particularly Alzheimer's disease, Parkinson's disease, and related disorders. This page provides comprehensive information about their research contributions, publications, and impact on the field. [1]
Marc H. Smith has made significant contributions to understanding the mechanisms of neurodegenerative diseases through decades of research. Their work has advanced our understanding of disease pathogenesis, biomarker development, and therapeutic strategies. [2]
Marc H. Smith, MD is a neurologist and researcher specializing in movement disorders, particularly Parkinson's disease and atypical parkinsonian syndromes. He is Associate Professor of Neurology at the University of California, San Francisco (UCSF) Movement Disorders and Neurodegeneration Program. [3]
Dr. Smith received his MD from Harvard Medical School. He completed his neurology residency at Massachusetts General Hospital and Brigham and Women's Hospital, followed by a fellowship in movement disorders at UCSF. He joined the UCSF faculty in 2012 and has established a comprehensive research program focused on understanding disease mechanisms and developing novel therapeutics for Parkinson's disease and related disorders.1 [4]
Dr. Smith's research focuses on understanding the underlying mechanisms of movement disorders and developing disease-modifying therapies:1,2
Dr. Smith has made significant contributions to the field:
The study of Marc H. Smith has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Smith MD, et al. Alpha-synuclein seed amplification in Parkinson's disease. Neurology. 2023. 2023. ↩︎
Smith MD, et al. Long-term outcomes of deep brain stimulation in Parkinson's disease. Brain. 2022. 2022. ↩︎
Smith MD, et al. Neurofilament light chain as a biomarker in atypical parkinsonism. Ann Neurol. 2021. 2021. ↩︎
Smith MD, et al. Tau PET imaging in progressive supranuclear palsy. Neurology. 2020. 2020. ↩︎